Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than those receiving placebo, according to trial findings published in The New England Journal of Medicine. “The results show that prevention of vertebral fractures in early postmenopausal women is possible with very infrequent infusions of zoledronate,” Mark J.
Searches PubMed for specific terms and generate report.
Entering 2025, adults with moderate to severe obstructive sleep apnea and obesity have a new FDA-approved treatment option that takes the form of a GIP/GLP-1…
The program theme: Endocrine Innovation & Obesity Breakthroughs will dive into groundbreaking approaches to metabolic disorders and obesity. Leading experts will share insights on the…
Assisted reproductive technology among patients with epilepsy requires variable and multistaged techniques and interdisciplinary collaboration.
The rates of opioid use disorder among pregnant people enrolled in Medicaid may be twice as high as prior estimates, according to a recent cross-sectional…
Screening for social risks in physician practices significantly increased over the last several years, according to a cross-sectional study published in JAMA Network Open.Still, less…
The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products.…
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for treatment of patients…
Our awards program supports your dedication to excellence in research, education, and clinical practice in endocrinology. View our open award opportunities and apply today or…
